MEDLINE Status: In-Data-Review
Issn Electronic: 1365-2133
Adjuvant irradiation to prevent keloidal fibroproliferative growth should be standard of care.
M K Ramirez-Fort; B Meier; A Feily; S L Cooper; C S Lange
Author Information: Radiation Oncology, Medical University of South Carolina, Charleston, SC, U.S.A.; Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Radiation Oncology, Medical University of South Carolina, Charleston, SC, U.S.A.; Radiation Oncology, State University of New York Downstate Medical Center, Brooklyn, NY, U.S.A.
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.